Journal of Microbiology

Hana Hyeon

2 Articles

Relaxed Cleavage Specificity of Hyperactive Variants of Escherichia coli RNase E on RNA I: Dayeong Bae , Hana Hyeon , Eunkyoung Shin , Ji&# , Kangseok Lee; J. Microbiol. 2023;61(2):211-220. Published online February 22, 2023; DOI: https://doi.org/10.1007/s12275-023-00013-z

533 View
3 Download
1 Web of Science
1 Crossref

RNase E is an essential enzyme in Escherichia coli. The cleavage site of this single-stranded specific endoribonuclease is well-characterized in many RNA substrates. Here, we report that the upregulation of RNase E cleavage activity by a mutation that affects either RNA binding (Q36R) or enzyme multimerization (E429G) was accompanied by relaxed cleavage specificity. Both mutations led to enhanced RNase E cleavage in RNA I, an antisense RNA of ColE1-type plasmid replication, at a major site and other cryptic sites. Expression of a truncated RNA I with a major RNase E cleavage site deletion at the 5′-end (RNA I- 5) resulted in an approximately twofold increase in the steady-state levels of RNA I- 5 and the copy number of ColE1-type plasmid in E. coli cells expressing wild-type or variant RNase E compared to those expressing RNA I. These
results
indicate that RNA I- 5 does not efficiently function as an antisense RNA despite having a triphosphate group at the 5′-end, which protects the RNA from ribonuclease attack. Our study suggests that increased cleavage rates of RNase E lead to relaxed cleavage specificity on RNA I and the inability of the cleavage product of RNA I as an antisense regulator in vivo does not stem from its instability by having 5′-monophosphorylated end.

Citations

Citations to this article as recorded by

Engineering an Escherichia coli based in vivo mRNA manufacturing platform
Edward Curry, George Muir, Jixin Qu, Zoltán Kis, Martyn Hulley, Adam Brown
Biotechnology and Bioengineering.2024; 121(6): 1912. CrossRef

Transcript-specific selective translation by specialized ribosomes bearing genome-encoded heterogeneous rRNAs in V. vulnificus CMCP6: Younkyung Choi , Minju Joo , Wooseok Song , Minho Lee , Hana Hyeon , Hyun-Lee Kim , Ji-Hyun Yeom , Kangseok Lee , Eunkyoung Shin; J. Microbiol. 2022;60(12):1162-1167. Published online November 24, 2022; DOI: https://doi.org/10.1007/s12275-022-2437-9

601 View
2 Download
2 Web of Science
2 Crossref

Abstract PDF

Ribosomes composed of genome-encoded heterogeneous rRNAs are implicated in the rapid adaptation of bacterial cells to environmental changes. A previous study showed that ribosomes bearing the most heterogeneous rRNAs expressed from the rrnI operon (I-ribosomes) are implicated in the preferential translation of a subset of mRNAs, including hspA and tpiA, in Vibrio vulnificus CMCP6. In this study, we show that HspA nascent peptides were predominantly bound to I-ribosomes. Specifically, I-ribosomes were enriched more than two-fold in ribosomes that were pulled down by immunoprecipitation of HspA peptides compared with the proportion of I-ribosomes in crude ribosomes and ribosomes pulled down by immunoprecipitation of RNA polymerase subunit ß peptides in the wild-type (WT) and rrnI-completed strains. Other methods that utilized the incorporation of an affinity tag in 23S rRNA or chimeric rRNA tethering 16S and 23S rRNAs, which generated specialized functional ribosomes in Escherichia coli, did not result in functional I-ribosomes in V. vulnificus CMCP6. This study provides direct evidence of the preferential translation of hspA mRNA by I-ribosomes.

Citations

Citations to this article as recorded by

Functional conservation of specialized ribosomes bearing genome-encoded variant rRNAs in Vibrio species
Younkyung Choi, Eunkyoung Shin, Minho Lee, Ji-Hyun Yeom, Kangseok Lee, Bashir Sajo Mienda
PLOS ONE.2023; 18(12): e0289072. CrossRef
Relaxed Cleavage Specificity of Hyperactive Variants of Escherichia coli RNase E on RNA I
Dayeong Bae, Hana Hyeon, Eunkyoung Shin, Ji-Hyun Yeom, Kangseok Lee
Journal of Microbiology.2023; 61(2): 211. CrossRef

Hana Hyeon

2 Articles

CRISPR-Cas technologies: Emerging tools from research to clinical application: Hana Hyeon, Soonhye Hwang, Yongyang Luo, Eunkyoung Shin, Ji-Hyun Yeom, Hong-Man Kim, Minkyung Ryu, Kangseok Lee; J. Microbiol. 2025;63(8):e2504012. Published online August 31, 2025; DOI: https://doi.org/10.71150/jm.2504012

15,330 View
223 Download
1 Web of Science
1 Crossref

Abstract PDF

CRISPR-Cas technologies have emerged as powerful and versatile tools in gene therapy. In addition to the widely used SpCas9 system, alternative platforms including modified amino acid sequences, size-optimized variants, and other Cas enzymes from diverse bacterial species have been developed to apply this technology in various genetic contexts. In addition, base editors and prime editors for precise gene editing, the Cas13 system targeting RNA, and CRISPRa/i systems have enabled diverse and adaptable approaches for genome and RNA editing, as well as for regulating gene expression. Typically, CRISPR-Cas components are transported to the target in the form of DNA, RNA, or ribonucleoprotein complexes using various delivery methods, such as electroporation, adeno-associated viruses, and lipid nanoparticles. To amplify therapeutic efficiency, continued developments in targeted delivery technologies are required, with increased safety and stability of therapeutic biomolecules. CRISPR-based therapeutics hold an inexhaustible potential for the treatment of many diseases, including rare congenital diseases, by making permanent corrections at the genomic DNA level. In this review, we present various CRISPR-based tools, their delivery systems, and clinical progress in the CRISPR-Cas technology, highlighting its innovative prospects for gene therapy.

Citations

Citations to this article as recorded by

CRISPR: a precise genome editing strategy for the treatment of hepatocellular carcinoma
Subhrojyoti Mukherjee, Manish Kumar
Expert Review of Anticancer Therapy.2025; : 1. CrossRef

Small regulatory RNAs as key modulators of antibiotic resistance in pathogenic bacteria: Yubin Yang, Hana Hyeon, Minju Joo, Kangseok Lee, Eunkyoung Shin; J. Microbiol. 2025;63(4):e2501027. Published online April 2, 2025; DOI: https://doi.org/10.71150/jm.2501027

8,533 View
314 Download
6 Web of Science
10 Crossref

Abstract PDF

The escalating antibiotic resistance crisis poses a significant challenge to global public health, threatening the efficacy of current treatments and driving the emergence of multidrug-resistant pathogens. Among the various factors associated with bacterial antibiotic resistance, small regulatory RNAs (sRNAs) have emerged as pivotal post-transcriptional regulators which orchestrate bacterial adaptation to antibiotic pressure via diverse mechanisms. This review consolidates the current knowledge on sRNA-mediated mechanisms, focusing on drug uptake, drug efflux systems, lipopolysaccharides, cell wall modification, biofilm formation, and mutagenesis. Recent advances in transcriptomics and functional analyses have revealed novel sRNAs and their regulatory networks, expanding our understanding of resistance mechanisms. These findings highlight the potential of targeting sRNA-mediated pathways as an innovative therapeutic strategy to combat antibiotic resistance, and offer promising avenues for managing challenging bacterial infections.

Citations

Citations to this article as recorded by

Current insights into the application of bacterial small RNAs in combating multidrug-resistant pathogens
Zeleke Ayenew, Tadesse Eguale, Abebaw Bitew, Eshetu Gadisa, Aklilu Feleke Haile
Scientific African.2026; 31: e03212. CrossRef
From Host-Derived Pressures to the Environmental Anti-Antimicrobial Peptides Resistome: Mechanisms, Reservoirs and Implications for Therapeutic Peptide Design
Yi Lu, Baomei Zhang, Zishuo Wang, Yidi He, Hezi Ge, Hongyue Ma, Pengfei Cui
Marine Drugs.2026; 24(2): 76. CrossRef
Omics Applification of Microalgae-Bacteria Consortium Wonders in Nutrients and Antibiotics Removal from Wastewater
Adamudu Alexander Ogwuche, Ebrima S. Jabbi, Sorie Kalie Bangura, Iyobosa Eheneden, Muhammed Bako
European Journal of Ecology, Biology and Agriculture.2026; 3(2): 53. CrossRef
Pathotype-specific antimicrobial resistance in diarrheagenic Escherichia coli: gene variants, resistance mechanisms, and evolution of treatment strategies
Dhamini Kamal Raj, Sai Kiruthiga Saravanan, Anumitha Viswanathan, Santhosh Mudipalli Elavarasu, Sidharth Kumar Nanda Kumar, K. S. Sridharan, Amudha Govindarajan, Sasikumar Krishnan, Magesh Ramasamy
Frontiers in Microbiology.2026;[Epub] CrossRef
Bacterial secondary metabolites as resistance-modifying adjuvants: microbial origins, molecular mechanisms, and translational relevance
Victor Uchenna Chigozie, Charles Okechukwu Esimone
Frontiers in Microbiology.2026;[Epub] CrossRef
Tackling antibiotic resistance in ESKAPE pathogens through the lens of bacterial small RNAs
Sijia Liu, Xiaorui Song, Kefeng Cui, Hongrui Zhu, Yuchun Liu, Rui Jia, Zhidan Yu, Huiqing Sun, Mingchao Li, Zengyuan Yu, Lifeng Li
Microbial Pathogenesis.2026; 215: 108487. CrossRef
Antechokinetics, the kinetics of antimicrobial resistance molecules
Fernando Baquero, Rafael Cantón, João Alves Gama, Jerónimo Rodríguez-Beltrán
Frontiers in Pharmacology.2026;[Epub] CrossRef
Small regulatory RNAs modulate lactococcal susceptibility to cell wall-targeting antimicrobials
Milda Mickutė, Kotryna Kvederavičiūtė, Janina Ličytė, Renatas Krasauskas, Sigita Grigaitytė, Oskaras Safinas, Danguolė Žiogienė, Naglis Mykolas Pakštys, Loreta Stankevičiūtė, Algirdas Kaupinis, Mindaugas Valius, Pascal Courtin, Marie-Pierre Chapot-Chartie
Nucleic Acids Research.2026;[Epub] CrossRef
Biofilm, resistance, and quorum sensing: The triple threat in bacterial pathogenesis
Mohammad Nazrul Islam Bhuiyan
The Microbe.2025; 9: 100578. CrossRef
Biofilm maturation in carbapenem-resistant Pseudomonas aeruginosa is regulated by the sRNA PA213 and its corresponding encoded small protein
Yongli Song, Jie Li, Yating Zhang, Lingge Su, Shuang Qin, Chunyan Wu, Guibo Song
International Journal of Antimicrobial Agents.2025; 66(6): 107625. CrossRef

Author index